Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • toots
    Junior Member
    • Oct 2012
    • 2

    #1

    Plotting distribution of allelic frequency under different coverage values

    I'm new to bioinformatics, and have an incomprehensible PI. Could someone clue me in on some of what is going on in the prompt below? For instance:
    1) What's "LD"?
    2) What do the different coverage values signify? How do I implement that in R?
    3) I have no idea what the RefAlleleCount, etc. bit means. Aren't all of those ratios the same anyhow?

    I realize I'm asking really broad, noobish questions, but a little context would be reeeaaally helpful. Thanks.

    " RNAseq reads covered 5,000 biallelic human autosomal SNPs (all are heterogeneous, assume they are not in LD). Please write simple R statements to plot the distribution of the alternative allelic frequency under sequencing coverage 2x, 5x, 10x, 20x, respectively. Also calculate the p-values with the hypothesis that there are no differential allelic expression for these three SNPs: (RefAlleleCount:AltAlleleCount) 1:4, 2:8, 4:16. "

    Edit: I've discovered that LD is linkage disequilibrium. Still fairly lost though.
    Last edited by toots; 10-22-2012, 08:36 AM.
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    1) LD = Linkage Disequalibrium
    2) Coverage refers to the number of reads covering each bp
    3) RefAlleleCount = # of reads with the reference allele, AltAlleleCount = # reads with an alternative allele (i.e. not matching the reference).

    Comment

    • toots
      Junior Member
      • Oct 2012
      • 2

      #3
      Is there actually enough information in that prompt to do an analysis in R? I don't even know which "three SNPs" are being referred to. Is that implicit somehow?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...